KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy

KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy

Abstract Background This study was carried out to evaluate the prognostic value of KIBRA in breast cancer. Methods This retrospective study included breast cancer patients who sought the services of the immunohistochemistry laboratory of our unit from 2006 to 2015. Tissue microarrays were constructe...

Full description

Bibliographic Details
Main Authors: Lakmini Mudduwa, Harshini Peiris, Shania Gunasekara, Deepthika Abeysiriwardhana, Nimsha Liyanage, Suresh K. Rayala, Thusharie Liyanage
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Cancer
Subjects:
ER
Endocrine therapy
Breast cancer
KIBRA
Recurrence free survival
Online Access:http://link.springer.com/article/10.1186/s12885-018-4491-6

Internet

http://link.springer.com/article/10.1186/s12885-018-4491-6

Similar Items